南京科融数据系统股份有限公司
100-499人
公司优势
南京科融数据系统股份有限公司拥有超过二十年的历史，是一家国家高新技术企业和南京市骨干软件企业，并通过了ISO9001和CMMI 3级认证。我们专注于应用软件系统开发、安防图像监控系统等领域，为金融、政府、保险等行业提供信息化服务。凭借专业的团队，我们提供先进技术和优质服务。公司在多个城市设有办事处，包括北京、上海、合肥、武汉等。
作为专业的非现场监管体系应用服务提供商和金融风险分析咨询服务商，我们拥有多款自主研发的金融类软件产品，如综合报送平台、监管分析平台、经营分析平台、综合管理平台、报告系统、绩效考核系统等。
我们的客户涵盖了众多金融机构，包括中国银行业监督管理委员会、中国工商银行总行、中国农业银行总行、中国银行总行、中国建设银行总行、中国农业发展银行总行、招商银行、浙商银行、恒丰银行、江苏银行、徽商银行、河北银行、青海银行、杭州银行、苏州银行、广东省联社、湖南省联社、汇丰银行、恒生银行、摩根大通、法国兴业等。
2016年，科融数据在“新三板”成功挂牌上市，股票简称“科融数据”，证券代码为“838395”。
热招职位
相关职位
热门城市
20,861+ 岗位更新等你来订阅
一键订阅最新的岗位，每周送达
🎉恭喜你，订阅成功
继续订阅您可以在邮箱中随时取消订阅
中环信（南京）环境服务有限公司现正公开招聘。
永康市薪火文化传播有限公司诚聘
东莞市晟高玩具有限公司，公司规模为少于50人，公司类型为民营公司，所属行业为家具/家电/玩具/礼品。
深圳市法莉娜餐饮管理有限公司，规模小于50人，属于民营企业，行业分类为餐饮业。
Bioworkshops Suzhou, a biopharmaceutical company headquartered in Hong Kong, collaborates with international partners to develop pioneering and superior antibody products for China and the global market. We specialize in creating clinical drug substances and products using cell culture methods, adhering to international standards. Our mission is to expedite the development and approval of biological products faster than any other Chinese competitor through the strategic application of manufacturing science.
Recently, the company has acquired a 28,000 square-meter facility in Suzhou and invested over RMB300 million in constructing state-of-the-art development and clinical manufacturing facilities in 2019. This investment positions us well to aim for the first IND approval in 2020.
Our team is comprised of talented and productive professionals, led by experienced founders from Australia and China who have a track record of launching and guiding biologics development and manufacturing organizations worldwide for over two decades. In the last five years alone, they've successfully launched more than ten new antibody products for the US, Australian, and Chinese markets, and completed the design, construction, and startup of four biologics development and manufacturing centers:
- Clinical and commercial production facilities
- Inspected for compliance with US-FDA, NMPA, TFDA, and TGA regulations for filing CTAs/INDs and commercial products
We've swiftly assembled a startup team and are actively recruiting additional experts to grow our workforce to over 150 employees within the next year.
Quality management is a critical component of our operations, requiring a deliberate approach with a commitment to continuous improvement. Bioworkshops' Quality Management System covers all aspects of our business, with a special emphasis on ensuring pharmaceutical product quality during development and manufacturing processes to meet Chinese, European, and American Good Manufacturing Practice (GMP) standards.
Our facility is situated in the heart of Suzhou Industrial Park, where we are constructing high-capacity drug discovery, development, and manufacturing facilities that include:
- Development capacity for up to 8-12 IND applications annually
- Clinical drug substance manufacturing to 2,000L scale
- Aseptic filling of liquid products into vials
- Best-in-class bioprocesses and analytical capabilities
At Bioworkshops, our founding values emphasize a strong culture and shared purpose, focusing on:
- Innovation and excellence in biologics development
- Trust-based relationships grounded in honesty
- Sustainability measured by workplace safety, environmental impact, and long-term business success
- Enthusiasm for ambitious goals and creative problem-solving
- Respect for the persistent effort required to achieve ambitious goals in our industry